TBP and cancer: Overall, this study identified BRF2 as a promising cancer target; indicated the molecular changes in the architecture of this protein via binding to TBP; provided the potential hit compounds for this target, followed by examining one of them experimentally, as well as examining new roles for BRF2 in DDR regulation.